Skip to article
Astra

Autonomic Medicine

Orthostatic Hypotension

Confirm a reproducible orthostatic blood-pressure fall, identify acute volume, medication, cardiac, or neurogenic drivers, and treat disabling cerebral hypoperfusion while avoiding treatment-induced supine hypertension.

Clinical question: How should clinicians confirm orthostatic hypotension, distinguish neurogenic from reversible causes, and manage symptomatic disease safely?

Initial Assessment

Confirm orthostatic hypotension and identify immediate hazards

Treat instability or an acute systemic cause before pursuing chronic autonomic phenotyping.

In a patient with syncope, recurrent falls, presyncope, or orthostatic intolerance, first determine whether hypotension is part of an immediately reversible hemodynamic problem. Assess pulse and rhythm, volume status, active bleeding risk, fever or infection, medication exposure, and cardiopulmonary findings; an irregular pulse should prompt caution with automated blood-pressure devices because they can overestimate systolic pressure in atrial fibrillation. BMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice

For diagnostic measurement, obtain supine blood pressure after 5 minutes of rest, then measure during standing through 3 minutes. Orthostatic hypotension is a systolic decrease of at least 20 mmHg, at least 30 mmHg in patients with hypertension, and/or a diastolic decrease of at least 10 mmHg within 3 minutes. Document symptoms at each time point because cerebral hypoperfusion symptoms, syncope, and falls determine clinical significance and treatment urgency. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practice

If bedside measurements are negative despite a compelling positional history, repeat standardized recordings when symptomatic or use head-up tilt assessment to reproduce the blood-pressure and heart-rate response. A single normal set of orthostatic vital signs should not terminate evaluation when episodes are intermittent, medication-related, or volume sensitive. ccjmEvaluation and management of orthostatic hypotension

Orthostatic vital-sign interpretation that changes the next diagnostic branch. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best PracticeBMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best PracticeccjmEvaluation and management of orthostatic hypotension
Observed responseInterpretationNext action
SBP fall >=20 mmHg, or >=30 mmHg with hypertension, and/or DBP fall >=10 mmHg within 3 minutesOrthostatic hypotension confirmed. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAssessment of hypotension - Differential diagnosis of symptoms | BMJ Best PracticeClassify heart-rate response and search for reversible versus neurogenic causes. ccjmEvaluation and management of orthostatic hypotension
Orthostatic BP fall with delta HR/delta SBP ratio <0.5Supports a neurogenic component; most neurogenic cases have ratio <0.3. ccjmEvaluation and management of orthostatic hypotensionAssess for autonomic failure, peripheral neuropathy, or synucleinopathy and consider formal autonomic evaluation when the cause remains uncertain. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentccjmEvaluation and management of orthostatic hypotension
Orthostatic BP fall with delta HR/delta SBP ratio >0.5More consistent with intact autonomic compensation and a non-neurogenic contributor, although specificity is imperfect. ccjmEvaluation and management of orthostatic hypotensionPrioritize volume loss, medication effects, and systemic or cardiac causes. BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension
HR increase >=30 bpm within 10 minutes of standing or tilt, no orthostatic hypotension, symptoms >=3 monthsMeets hemodynamic and duration elements of POTS when alternative causes of sinus tachycardia are excluded. BMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best PracticeDo not treat as orthostatic hypotension; evaluate and manage as POTS. BMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice

Differential Diagnosis

Use heart-rate compensation to separate reversible from neurogenic hypotension

The standing heart-rate response is a practical discriminator, but medication effects and rhythm disorders can confound it.

A preserved tachycardic response to falling blood pressure favors non-neurogenic orthostatic hypotension. Review for reduced effective circulating volume, acute or chronic blood loss, and drugs that impair volume or vascular compensation; non-neurogenic causes can also substantially worsen pre-existing autonomic failure. BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension The immediate next step is targeted reversal of the identified driver rather than empiric long-term pressor therapy.

A blunted heart-rate response—particularly delta heart rate/delta systolic blood pressure below 0.5—supports impaired baroreflex-mediated autonomic compensation. The ratio had reported sensitivity of 91% and specificity of 88% in one study, but later work found specificity as low as 50%; interpret it with the clinical context rather than as a stand-alone diagnosis. ccjmEvaluation and management of orthostatic hypotension Peripheral neuropathy and synucleinopathies are named neurogenic causes, and coexisting supine hypertension increases the likelihood that management will require a pressor-risk tradeoff. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet

For persistent, unexplained, or progressive suspected neurogenic orthostatic hypotension, escalate phenotyping according to associated neurologic and systemic findings. Available formal evaluations include autonomic nervous system testing, electromyography and nerve-conduction studies, skin biopsy for nerve-fiber density, serum paraneoplastic and autoimmune neuroautoantibody panels, and abdominal fat-pad biopsy. ccjmEvaluation and management of orthostatic hypotension Select these studies to test a specific suspected autonomic neuropathy, paraneoplastic/autoimmune process, or amyloid process rather than ordering a uniform panel.

Etiologic branches and targeted escalation in confirmed orthostatic hypotension. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJAutonomic diseases: clinical features and laboratory evaluationThe LancetDiagnosis and treatment of orthostatic hypotension - The LancetccjmEvaluation and management of orthostatic hypotension
BranchClinical patternAction
Non-neurogenic orthostatic hypotensionOrthostatic BP fall with preserved heart-rate compensation; volume, medication, or systemic contributors may be present. BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotensionIdentify and correct the precipitating contributor; reassess orthostatic vitals after the intervention. BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotension
Neurogenic orthostatic hypotensionOrthostatic BP fall with inadequate heart-rate compensation; peripheral neuropathy and synucleinopathies are representative causes. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentccjmEvaluation and management of orthostatic hypotensionAssess neurologic and autonomic features; use autonomic testing and targeted neuropathy, antibody, or tissue evaluation when clinically indicated. ccjmEvaluation and management of orthostatic hypotension
Orthostatic hypotension with supine hypertensionSupine hypertension coexists with symptomatic standing hypoperfusion. The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...Balance symptom-directed standing BP treatment against worsened supine hypertension; monitor both positions during titration. The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...

Management

Treat functional impairment while minimizing supine hypertension

The treatment target is safer upright function, not normalization of a standing blood-pressure value.

Start by correcting reversible causes and reducing exposures that contribute to orthostatic blood-pressure failure. Recheck supine and standing pressures after each meaningful medication or volume intervention, because treatment response determines whether residual autonomic failure is clinically important. In patients with autonomic failure, non-neurogenic stressors may enhance orthostatic hypotension considerably. BMJAutonomic diseases: clinical features and laboratory evaluation

For severe orthostatic hypotension due to autonomic dysfunction after corrective factors have been excluded and other measures are inadequate, midodrine is a treatment option. BMJMidodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletin Its use requires position-specific blood-pressure surveillance because standard drug treatment can worsen supine hypertension. The LancetManagement of neurogenic orthostatic hypotension: an updateThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet Avoid evaluating benefit only from an office standing measurement; reassess dizziness, presyncope, falls, and ability to remain upright for required activities.

Droxidopa increases norepinephrine availability and sympathetic tone; fludrocortisone expands volume through sodium and water retention but requires caution for supine hypertension and hypokalemia. Pyridostigmine augments sympathetic ganglionic transmission and may improve standing vascular resistance without significantly affecting supine blood pressure; published reviews describe its benefit as modest. The LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ... Choice should be driven by the patient’s dominant physiologic deficit and supine blood-pressure liability rather than routine combination treatment.

Medication-selection considerations for neurogenic orthostatic hypotension. BMJMidodrine for severe orthostatic hypotension | Drug and Therapeutics BulletinThe LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ...
OptionPotential roleKey tradeoff or monitoring
MidodrineOption for severe orthostatic hypotension due to autonomic dysfunction when corrective factors are excluded and other treatments are inadequate. BMJMidodrine for severe orthostatic hypotension | Drug and Therapeutics BulletinStandard drug treatment may worsen supine hypertension; monitor blood pressure in supine and standing positions. The LancetManagement of neurogenic orthostatic hypotension: an updateThe LancetDiagnosis and treatment of orthostatic hypotension - The Lancet
DroxidopaRaises norepinephrine availability to improve sympathetic tone and orthostatic symptoms. NatureDiabetic neuropathy: cutting-edge research and future ...Monitor for supine hypertension during use. NatureDiabetic neuropathy: cutting-edge research and future ...
FludrocortisoneExpands plasma volume through sodium and water retention. NatureDiabetic neuropathy: cutting-edge research and future ...Use cautiously because of supine hypertension and hypokalemia; monitor potassium and position-specific blood pressure. NatureDiabetic neuropathy: cutting-edge research and future ...
PyridostigmineMay increase vascular resistance during standing and modestly improve orthostatic hypotension. The LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ...May avoid significant worsening of supine blood pressure, but benefit may be limited. The LancetManagement of neurogenic orthostatic hypotension: an updateNatureDiabetic neuropathy: cutting-edge research and future ...

Supine hypertension changes the treatment threshold

Supine hypertension is common in orthostatic hypotension and can be aggravated by therapies intended to raise standing blood pressure. The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ... The practical consequence is not to withhold all treatment automatically, but to use symptom burden, fall/syncope risk, upright functional impairment, and paired supine-standing measurements to determine whether the benefit of a pressor regimen justifies its nocturnal or supine blood-pressure risk.

Monitoring

Reassess by posture, symptoms, and cause-specific progression

Monitoring should detect both recurrent upright hypoperfusion and treatment-related supine hypertension.

At follow-up, repeat standardized supine and standing blood pressure and heart rate, record interval syncope, falls, presyncope, and upright activity limitation, and compare findings with the pre-intervention pattern. Orthostatic hypotension is clinically consequential when cerebral hypoperfusion produces symptoms and can lead to syncope and falls. BMJOrthostatic hypotension - Symptoms, diagnosis and treatment Persistent symptoms despite correction of reversible contributors should prompt reassessment for neurogenic disease or an unrecognized systemic cause.

Escalate to formal autonomic and neurologic evaluation when there is a reproducible blunted chronotropic response, progressive symptoms, neuropathic features, or suspicion for synucleinopathy. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentccjmEvaluation and management of orthostatic hypotension Use electromyography/nerve-conduction studies, skin biopsy, antibody testing, or fat-pad biopsy selectively when their result would establish a treatable or prognostically important etiology. ccjmEvaluation and management of orthostatic hypotension

Do not make treatment decisions from a single blood-pressure domain. Pressor therapy may improve standing blood pressure while worsening supine hypertension, and the evidence base for many interventions remains heterogeneous with inconsistent symptom and postural-blood-pressure outcomes. The LancetManagement of neurogenic orthostatic hypotension: an updateThe LancetDiagnosis and treatment of orthostatic hypotension - The LancetWolters KluwerEfficacy of treatments for orthostatic hypotension : Age and Ageing For refractory cases, define success as improved safety and function with an acceptable supine blood-pressure tradeoff.

Follow-up findings that should change management. BMJOrthostatic hypotension - Symptoms, diagnosis and treatmentBMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best PracticeThe LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...ccjmEvaluation and management of orthostatic hypotension
Follow-up findingInterpretationNext step
Symptoms and orthostatic BP fall resolve after reversible-factor correctionA non-neurogenic contributor was clinically important. BMJAutonomic diseases: clinical features and laboratory evaluationccjmEvaluation and management of orthostatic hypotensionContinue surveillance for recurrence and avoid unnecessary chronic pressor therapy. BMJAutonomic diseases: clinical features and laboratory evaluation
Persistent BP fall with blunted HR responseNeurogenic component remains likely. ccjmEvaluation and management of orthostatic hypotensionPursue targeted autonomic and neurologic evaluation. ccjmEvaluation and management of orthostatic hypotension
Improved standing symptoms but increased supine BPTreatment-related supine hypertension tradeoff. The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...Reassess regimen intensity and monitor both positions before further escalation. The LancetDiagnosis and treatment of orthostatic hypotension - The LancetNatureDiabetic neuropathy: cutting-edge research and future ...
Orthostatic tachycardia without BP fallOrthostatic hypotension is not demonstrated; consider POTS criteria and exclusions. BMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best PracticeRedirect diagnostic evaluation to causes of sinus tachycardia and POTS when duration criteria are met. BMJPostural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practice

References

  1. Orthostatic hypotension - Symptoms, diagnosis and treatmentbestpractice.bmj.com · bestpractice.bmj.com
  2. Assessment of hypotension - Differential diagnosis of symptoms | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  3. Postural orthostatic tachycardia syndrome - Symptoms, diagnosis and treatment | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  4. Midodrine for severe orthostatic hypotension | Drug and Therapeutics Bulletindtb.bmj.com · dtb.bmj.com
  5. Effects of intensive blood pressure treatment on orthostatic ...www.bmj.com · www.bmj.com
  6. Autonomic diseases: clinical features and laboratory evaluationjnnp.bmj.com · jnnp.bmj.com
  7. Orthostatic hypotension - Symptoms, diagnosis and treatment | BMJ ...bestpractice.bmj.com · bestpractice.bmj.com
  8. Management of neurogenic orthostatic hypotension: an updatewww.thelancet.com · www.thelancet.com
  9. Diagnosis and treatment of orthostatic hypotension - The Lancetwww.thelancet.com · www.thelancet.com
  10. Orthostatic Hypotension: a clinical marker for the body-first subtype of patients with Parkinson’s Disease | npj Parkinson's Diseasewww.nature.com · www.nature.com
  11. Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension | Hypertension Researchwww.nature.com · www.nature.com
  12. Orthostatic hypotension without co-existent supine hypertension is associated with impaired cerebral oxygenation: findings from the Irish Longitudinal Study on Ageing (TILDA) | Journal of Human Hypertensionwww.nature.com · www.nature.com
  13. Diabetic neuropathy: cutting-edge research and future ...www.nature.com · www.nature.com
  14. Efficacy of treatments for orthostatic hypotension : Age and Ageingjournals.lww.com · journals.lww.com
  15. Review of management strategies for orthostatic hypotension in ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  16. Orthostatic Hypotension Associated With Baroreceptor Dysfunction ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  17. Characteristics, Management, and Outcomes of Hospitalized ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  18. Measurement and management of adult blood pressure in the peri ...associationofanaesthetists-publications.onlinelibrary.wiley.com · associationofanaesthetists-publications.onlinelibrary.wiley.com
  19. Postural orthostatic tachycardia syndrome: clinical presentation ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  20. Pyridostigmine for the Management of Neurogenic Orthostatic ...journals.lww.com · journals.lww.com
  21. Treatment of autonomic dysfunction in Parkinson disease and ...movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
  22. Approach to Cardiovascular Autonomic Dysfunction in Patients with ...movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
  23. Orthostatic hypotension and cognitive impairment in ...movementdisorders.onlinelibrary.wiley.com · movementdisorders.onlinelibrary.wiley.com
  24. Evaluation and management of orthostatic hypotensionwww.ccjm.org · www.ccjm.org